Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ATCC CD34+ Progenitor Cells; derived from BXS0117; Induced Pluripotent Stem Cell; Human (Homo sapiens)
Supplier: ATCC ACS7020
iPSC-derived CD34+ Cells, BXS0117 are induced pluripotent stem cells that have been differentiated into hematopoietic progentitor CD34+ cells. These cells can be further differentiated down common lymphoid progenitor and common myeloid progenitor lineages. iPSC-derived CD34+ Cells can be used in cancer immunology research, drug development, toxicity screening, and blood lineage differentiation studies.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?